Table 1 Age and sTGFβrIII plasma concentrations in included women. Data are median (quartiles; range) or mean ± SD (range)
Women without breast carcinoma | Women with breast carcinoma | ||||
|---|---|---|---|---|---|
Healthy women | Benign lesions | All | AJCC stage 0-I | AJCC stage IIA-B | |
N | 158 | 65 | 147 | 93 | 54 |
Age (years) | 41 (37-56; 19-87) | 42 (35-48; 18-72) | 63 (50-69; 20-86) | 63 (50-70; 31-79) | 63 (50-69; 29-86) |
sTGFβrIII (ng/mL) | 97 ± 33 (29-215) | 85 ± 28 (32-153) | 111 ± 31 (6.3-230) | 110 ± 33 (6.3-230) | 113 ± 27 (52-190) |